Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$92,310,611
+$92,310,611 QoQ
Shares Held
366,836
Ownership
0.021%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#265
of 4,153 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2026CallValue
$2,919,024
CallShares
11,600
PutValue
$2,491,236
PutShares
9,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $681,590,231 across 11 Drug Manufacturers - General names. ABBV ranks #4 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
1,437,685 | $181,637,122 | |
| 2 | GSK |
GSK plc
|
2,652,881 | $139,064,022 | |
| 3 | AZN |
Astrazeneca PLC
|
711,547 | $134,923,542 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
366,836 | $92,310,611 | |
| 5 | MRK |
Merck & Co., Inc.
|
380,081 | $48,840,408 | |
| 6 | SNY |
Sanofi
|
820,078 | $34,984,527 | |
| 7 | BIIB |
Biogen Inc.
|
88,149 | $19,045,472 | |
| 8 | NVS |
Novartis AG
|
106,157 | $16,636,925 |
All Filings in ABBV
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,491,236 | 9,900 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $92,310,611 | 366,836 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $2,919,024 | 11,600 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $4,893,525 | 22,500 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $3,827,824 | 17,600 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $6,694,757 | 29,300 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $17,388,089 | 76,100 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $83,225,663 | 359,444 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $967,080 | 5,210 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,190,400 | 20,000 | Call | Defined | 2025-07-21 | |
| 2025-03-31 | $14,666,400 | 70,000 | Put | Defined | 2025-07-21 | |
| 2024-03-31 | $7,673,329 | 42,138 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,073,050 | 65,000 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $122,038,875 | 787,500 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $152,320,538 | 1,021,874 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $83,667,195 | 620,999 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $163,975,793 | 1,028,900 | Shares | Defined | 2023-05-15 | |
| 2021-03-31 | $10,822,000 | 100,000 | Put | Defined | 2021-05-17 | |
| 2020-12-31 | $5,833,888 | 54,446 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $7,655,453 | 87,401 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $24,351,389 | 248,028 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $105,973,128 | 1,390,906 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||